---
title: "000908.SZ (000908.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/000908.SZ/news.md"
symbol: "000908.SZ"
name: "000908.SZ"
parent: "https://longbridge.com/en/quote/000908.SZ.md"
datetime: "2026-03-04T20:49:46.952Z"
locales:
  - [en](https://longbridge.com/en/quote/000908.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000908.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000908.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/000908.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/000908.SZ/news.md)


# 000908.SZ (000908.SZ) — Related News

### [ST JINGFENG: Capital reserve fund conversion to increase share capital may lead to downward ex-rights in stock price](https://longbridge.com/en/news/276710424.md)
*2026-02-24T09:22:16.000Z*
> JINGFENG PHARMACEUTI announced that on February 3, 2026, the Changde Intermediate People's Court ruled to approve the "R

### [ST JINGFENG: Restructuring investment amount of 2.061 billion yuan has been received](https://longbridge.com/en/news/275113644.md)
*2026-02-06T10:56:51.000Z*
> ST JINGFENG announced that as of February 6, 2026, the company's management account has received all the restructuring i

### [ST JINGFENG's reorganization plan has been approved by the court](https://longbridge.com/en/news/274636169.md)
*2026-02-03T10:16:03.000Z*
> ST JINGFENG PHARMACEUTI announced that the company received a ruling from the Intermediate People's Court of Changde Cit

### [ST JINGFENG: The reorganization plan will convert every 10 shares into 10 additional shares](https://longbridge.com/en/news/274633289.md)
*2026-02-03T09:51:54.000Z*
> ST JINGFENG announced that the reorganization plan will be based on the existing share capital of JINGFENG PHARMACEUTI, 

### [ST JINGFENG PHARMACEUTI: Expected net profit for 2025 to be negative](https://longbridge.com/en/news/274141431.md)
*2026-01-29T11:33:59.000Z*
> ST JINGFENG PHARMACEUTI announced that it expects a net profit for the fiscal year 2025 to be negative, with an estimate

### [ST JINGFENG PHARMACEUTI: The company and its subsidiaries have a cumulative amount involved in legal cases reaching 12.7233 million yuan](https://longbridge.com/en/news/273683506.md)
*2026-01-26T10:06:14.000Z*
> ST JINGFENG announced that as of the date of the announcement, the total amount involved in litigation and arbitration m

### [JINGFENG PHARMACEUTI: Shares of the controlling shareholder have been partially frozen by judicial order, and control may change](https://longbridge.com/en/news/273498320.md)
*2026-01-23T09:49:58.000Z*
> JINGFENG PHARMACEUTI announced that part of the shares held by its controlling shareholder Ye Xiangwu have been judicial

### [ST JINGFENG: Stock abnormal fluctuations, warning of restructuring and multiple operational risks](https://longbridge.com/en/news/265684846.md)
*2025-11-13T09:41:11.000Z*
> ST JINGFENG announced that due to the cumulative deviation of the closing price increase over three consecutive trading 

### [JINGFENG PHARMACEUTI: Independent director Liu Ting resigned for personal reasons](https://longbridge.com/en/news/265110842.md)
*2025-11-10T09:44:52.000Z*
> JINGFENG PHARMACEUTI announced that independent director Liu Ting resigned for personal reasons and applied to resign fr